NET PROFIT (x1000 NOK)
EMPLOYEES
Pharmnovo AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/06 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
1
|
1,429
|
106 |
| Earnings before taxes |
-25,012
|
-69,749
|
-25,747 |
| EBITDA |
-25,429
|
-68,414
|
-25,604 |
| Total assets |
16,692
|
24,423
|
26,213 |
| Current assets |
16,602
|
24,334
|
26,098 |
| Current liabilities |
4,097
|
3,527
|
2,523 |
| Equity capital |
12,549
|
20,851
|
23,648 |
| - share capital |
591
|
419
|
332 |
| Employees (average) |
4
|
3
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/06 |
| Solvency |
75.2%
|
85.4%
|
90.2% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-149.8%
|
-279.7%
|
-97.8% |
| Current ratio |
405.2%
|
689.9%
|
1034.4% |
| Return on equity (ROE) |
-199.3%
|
-334.5%
|
-108.9% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
1
|
2
|
0 |
| Chg. No. of employees % |
33%
|
200%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.